Overall our data depict a complex regulation of IL-8 production in CRC and identify a BRAF/ERK2/CHOP axis which dictates the overall effect of pharmacological MAPK manipulation in different genetic contexts. The gene discussed is CXCL8; the disease is colorectal carcinoma.